June 2, 2020
MALVERN, P.A., June 2, 2020 — To drive high quality patient data collection in clinical trials, YPrime, a global leader of Interactive Response Technology (IRT) and electronic Clinical Outcome Assessments (eCOA) today announced the release of its fourth-generation eCOA platform. The platform is designed to promote data integrity, accuracy, and completeness through a feature-rich user experience, domain-expert support, and real-time data visibility for clinical trial sponsors.
Pairing modern software development techniques with a highly configurable eCOA authoring environment, the platform enables study teams to efficiently build and deploy electronic assessments across global clinical trials. YPrime’s development approach blends iterative design and testing to support predictable delivery timelines, improved system reliability, and positive user experiences for patients and sites.
This approach directly impacts study efficiency, data quality, and operational confidence throughout the clinical trial lifecycle.
“The rapid adoption of eCOA is driving the digital transformation of clinical research,” said Michael Hughes, Senior Vice President, Product Development, and Aubrey Llanes, eCOA Product Director at YPrime. “The shift toward virtual and decentralized trials places patients at the center of activity. Our eCOA platform supports this shift through user-centric design for patients and sites, paired with real-time data access and control for sponsors.”
In addition to software innovation, YPrime’s device manufacturing and provisioning strategy is designed to support optimal performance, security, and supply chain stability for eCOA deployments. Devices are purpose-built for clinical trials and configured exclusively for eCOA use, helping maximize battery life, operating speed, and reliability in global studies. Other key capabilities of YPrime’s eCOA solution include:
-
Intelligent device synchronization, allowing site users to move between devices without missing or duplicating data and eliminating the need to assign patients to specific devices
-
Real-time inventory management through a sponsor portal, providing continuous visibility into device status and location
-
Automated data correction workflows that streamline review, approval, and implementation in minutes instead of weeks
-
Web-backup solutions to ensure uninterrupted data collection in the event of device loss or damage
All eCOA deployments are supported by experienced project managers and global helpdesk coverage, ensuring fit-for-purpose study design, proactive risk management, and rapid resolution of technical issues. YPrime’s eCOA scientists are also available for consultation to support implementations aligned with industry best practices and regulatory expectations.
To learn more about YPrime eCOA, visit www.yprime.com/ecoa.